Key Insights

Highlights

Success Rate

67% trial completion

Treatment Research

10 treatments under study, led by Amt Bridlepro Device

Research Leaders

8 sponsors active, led by Boston Scientific Corporation

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

150%

3 of 2 completed with results

Key Signals

3 with results67% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (4)
Phase 4 (1)

Trial Status

Completed2
Unknown2
Not Yet Recruiting1
Terminated1
Withdrawn1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06772285Not Yet RecruitingPrimary

Albert Health App PEG Study

NCT05653843Completed

MANTIS Endoscopic Clipping Study

NCT05288556Not ApplicableTerminatedPrimary

Safety and Efficacy of Enteral Feeding Tube Stoma Site Accessory

NCT05557396Not ApplicableWithdrawnPrimary

Internal Tube Length of the Nasogastric Tube

NCT04621734Not ApplicableCompletedPrimary

Retention of Nasoenteric Feeding Tubes in Pediatric Patients Using a Nasal Bridle

NCT05694299Not ApplicableUnknownPrimary

Nasal Bridle Versus Nasal Patch for Fixation of Nasoenteral Feeding Tubes

NCT04627844Phase 4UnknownPrimary

Time to Feeding After PEG Tube Placement.

Showing all 7 trials

Research Network

Common Treatments

  • Amt Bridlepro Device1
  • Albert Health App1
  • Immediate Feeding1
  • Placement Of Stoma Site Enteral Feeding Tube Accessory1
  • Nasal Patch1

Active Sponsors

  • Boston Scientific Corporation1
  • Medisch Spectrum Twente1
  • The Royal Wolverhampton Hospitals NHS Trust1
  • Eric Yudelevich1
  • Augusta University1

Top Investigators

Related Conditions

  • Hemostasis1
  • Feeding Disorders1
  • Perforation Colon1
  • Endoscopy1

Activity Timeline